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background: Intact frozen-thawed embryos have a greater potential than damaged embryos to establish successful pregnancies. This
study aimed to determine whether elevated concentrations of sucrose during freezing would increase the proportion of patients with ≥50%
of embryos intact after thawing (primary outcome), and improve clinical outcome.
methods: In a two arm, parallel group, pragmatic trial, IVF/ICSI couples were randomized prospectively to have their supernumerary
embryos frozen in a medium containing 0.1 M sucrose (control; n ¼ 99) or 0.3 M sucrose (intervention; n ¼ 102).
results: More control (74/99) than intervention (63/102) couples had at least one embryo thawed (P ¼ 0.07). Signiﬁcantly more
(P ¼ 0.005) intervention (53/63) than control (45/74) couples had ≥50% of embryos intact. Freezing in a medium containing 0.3 M
sucrose increased by 3.4-fold [95% conﬁdence interval (CI) (1.45, 7.82)] the likelihood of a couple having ≥50% of their embryos
intact. In the fresh cycle, live birth rate per transfer was similar in the control (35/95) and intervention (36/93) groups (P ¼ 0.91).
More control (19/63) than intervention (9/59) couples had a live birth after frozen embryo transfer (P ¼ 0.08). When fresh and
frozen cycles were combined, fewer intervention (n ¼ 102) than control (n ¼ 99) couples had at least one live birth (42 versus 53%).
The difference in cumulative live birth rate was not signiﬁcant [hazard ratio ¼ 0.75, 95% CI (0.49, 1.13); P ¼ 0.17].
conclusions: Increasing the concentration of sucrose in the freezing medium improves embryo survival, but this is not reﬂected by
increased cumulative birth rates.
Clinical Trials Registration number: ISRCTN93314892.
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Introduction
Embryo freezing has been an integral part of assisted reproduction for
at least two decades, despite the knowledge that many embryos are
damaged in the process, resulting in reduced pregnancy and delivery
rates (Van den Abeel et al., 1997; Guerif et al., 2002; de Mouzon
et al., 2010). The key advantage of cryopreserving supernumerary
embryos is to maximize the chance of a live birth from a single
cycle of ovarian stimulation while limiting the risk of multiple birth.
The increasing use of elective single embryo transfer (eSET) as a
means of minimizing iatrogenic multiples in IVF has re-focused
attention on embryo cryopreservation as a means of maintaining
cumulative birth rates (Tiitinen et al., 2001; Thurin et al., 2004;
Veleva et al., 2006, 2009). However, critical to the acceptance of
eSET is the ability to access robust cryopreservation methods with
reliably high rates of embryo survival and subsequent live birth.
Conventionally, embryos are considered to have survived freezing
and thawing when at least 50% of blastomeres remain intact (e.g. Las-
salle et al., 1985; Mohr et al., 1985; Testart et al., 1987; Van Steirte-
ghem et al., 1987). However, blastomere loss is associated with
reduced developmental potential of the embryos in vitro (Archer
et al., 2003), and reduced rates of implantation and pregnancy
& The Author 2011. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology.
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.5), which
permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Human Reproduction, Vol.26, No.8 pp. 1987–1996, 2011
Advanced Access publication on May 16, 2011 doi:10.1093/humrep/der147(Van den Abbeel et al., 1997; Burns et al., 1999; Edgar et al., 2000;
Guerif et al., 2002; El-Toukhy et al., 2003; Pal et al., 2004) as well
as reduced rates of live birth (Van den Abbeel et al., 1997; Guerif
et al., 2002). Retrospective analyses of large data sets suggest that
frozen embryos surviving with all blastomeres intact have an implan-
tation potential similar to that of fresh embryos at the same develop-
mental stage (Edgar et al., 2000). Typically, only about 50% of embryos
survive freezing without loss of blastomeres (Mandelbaum et al., 1988;
Edgar et al., 2000; Archer et al., 2003; Kattera and Chen, 2005;
Balaban et al., 2008). Thus, there is a clear and urgent need to
improve methods of cryopreservation that increase the proportion
of embryos surviving freezing with all blastomeres intact.
Pronucleate and cleavage stage embryos are frozen almost univer-
sally in a medium containing 1,2-propanediol (PrOH;  1.5 M) and
sucrose (0.1 M), according to protocols based on the method devel-
oped 26 years ago for mouse embryos (Renard and Babinet, 1984)
and modiﬁed for human embryos a year later (Lassalle et al., 1985).
Lassalle et al. (1985) froze embryos in solutions with or without
0.1 M sucrose, but had insufﬁcient evidence to comment on the
value of adding sucrose. Testart et al. (1986) froze embryos in
medium with sucrose (0.1 M) and reported high pregnancy rates,
while Mandelbaum et al. (1988) found that embryo survival was
improved when sucrose (0.1 M) was added to the medium. With
notable exceptions (Van den Abbeel et al., 1988; Van der Elst et al.,
1995), freezing in a solution of 1.5 M PrOH and 0.1 M sucrose has
been largely unchallenged until recently (Jericho et al., 2003; Edgar
et al., 2009).
Human oocytes are particularly sensitive to freezing, and rates of
post-thaw survival were unacceptably low for many years. Raising
the concentration of sucrose in the freezing medium 2- and 3-fold
from 0.1 M increased oocyte survival from 31 to 60% and 80%
(Fabbri et al., 2001). Similarly, the survival of biopsied (Jericho et al.,
2003; Zheng et al., 2005) and non-biopsied (Edgar et al., 2009)
embryos was improved signiﬁcantly after freezing in a medium contain-
ing 0.2 M sucrose.
The aim of this pragmatic RCT was to compare the survival of
supernumerary pronucleate and cleavage stage embryos frozen in a
solution of PrOH with either the conventional concentration (0.1 M)
or an elevated concentration (0.3 M) of sucrose. The primary end-
point was the proportion of couples with at least 50% of embryos
fully intact after thawing. Cumulative live birth after the transfer of
embryos in the oocyte collection cycle and in one or more thawing
cycles was a secondary end-point.
Materials and Methods
Participants and study design
The study was a two arm, parallel group, pragmatic RCT. Couples were
recruited from one major teaching hospital in the northeast of Scotland.
All couples attending the Assisted Reproduction Unit (ARU), University
of Aberdeen, for IVF or ICSI treatment between September 2003 and
December 2006 were considered for inclusion. Exclusion criteria were
(i) women with no supernumerary embryos for freezing in two previous
treatment cycles, (ii) women ≥38 years of age with one previous cycle
without freezing, (iii) couples using donor gametes and (iv) couples
recruited to any other ongoing clinical trial. The trial was approved by
the Grampian Research Ethics Committee and the Human Fertilization
and Embryology Authority of the UK. Written informed consent was
obtained from all couples who participated.
Stimulation, oocyte collection, fertilization
and embryo culture
Standard protocols for ovarian stimulation in IVF were followed (Bhatta-
charya et al., 2001; Haggarty et al., 2006). Follicles were aspirated trans-
vaginally under ultrasound guidance at 36–38 h post hCG injection.
Oocyte–cumulus complexes (OCCs) were handled on heated stages in
medium (Medicult Universal Medium until May 2005, thereafter Cook’s
Fertilization Medium) warmed to 378C. For IVF the OCCs were mixed
with sperm 40–41 h post hCG. For ICSI the cumulus cells were
removed enzymatically and sperm injected at 40–42 h post hCG.
Oocytes were examined for the presence of pronuclei and polar bodies
18–20 h post insemination (p.i.). Normally fertilized eggs with two pronu-
clei and two polar bodies were either cultured under oil in 30 ml drops of
medium (Medicult Universal Medium until May 2005, Cook’s Cleavage
Medium thereafter) at 378C in an atmosphere of 5–6% CO2 in air, or
frozen immediately. The cultured embryos were examined microscopically
 3 h before transfer on Day 2 or Day 3 p.i.; the ﬁnal selection for transfer
and freezing was made just before embryo transfer.
Freezing and thawing
Freezing and thawing protocols were identical for embryos in the control
(conventional concentration of sucrose) and intervention (increased con-
centration of sucrose) groups, but the freezing and thawing solutions dif-
fered. Medicult freezing solution no. 10264010 (1.5 M PrOH + 0.1 M
sucrose) and thawing solution no 10984010 (0.2 M sucrose) were used
for control embryos and freezing solution no. 10485010 (1.4 M PrOH +
0.3 M sucrose) and thawing solution no 10494010 (0.3 M sucrose) for inter-
vention embryos.
Embryos were prepared for freezing at room temperature ( 228C).
They were washed brieﬂy (1–2 min) in Dulbecco’s phosphate-buffered
saline (PBS) supplemented with human serum albumin (HSA) and syn-
thetic serum replacement (PBS + HSA + SSR: control embryos) or
PBS + HSA + alpha- and beta-globulins (PBS + HSA + G: intervention
embryos), and then transferred into a similar buffer + PrOH for 12 min
and ﬁnally into the freezing medium (buffer + PrOH + sucrose) for
5–10 min before cooling. Embryos were frozen singly in sealed straws.
Cooling commenced at 28C per minute to 278C, the sample was
seeded, and 10 min later cooling was resumed at 0.38Cp e rm i n u t et o
2308Ca n dt h e na t1 0 8C per minute to 21508C before the straws
were transferred into liquid nitrogen for storage at 21968C.
For thawing, the straw was held in air at room temperature for 40 s and
then immersed in water at 258C until the ice disappeared. Embryos were
transferred sequentially at 5 min intervals at room temperature through
aliquots of buffer containing sucrose (control: PBS + HSA + SSR +
0.2 M sucrose; intervention: PBS + HSA + G + 0.3 M sucrose) and
decreasing concentrations of PrOH (control: 1.0 M, 0.5 M; intervention:
0.9 M, 0.4 M) and ﬁnally into buffer without sucrose. The morphology
of the embryo was recorded and then it was cultured under oil in a
30 ml drop of medium (Medicult Universal or Cook’s Cleavage Medium)
at 378C in an atmosphere of 5–6% CO2 in air until transfer.
Embryos were frozen after the fresh embryo transfer on Day 2 or Day 3
p.i., except for couples in which the woman was at risk of developing
ovarian hyperstimulation syndrome (OHSS). In the latter cases, no
embryos were transferred in the fresh cycle and instead, all embryos
were frozen at the pronucleate stage on Day 1 and/or after cleavage on
Day 2. Embryos were thawed on the day before the intended transfer
and then cultured overnight (pronucleate and Day 2 embryos), or
thawed and cultured for up to 6 h on the day of transfer (Day 2 and
1988 Wood et al.Day 3 embryos). Unless the couple wished otherwise, embryos were
thawed until two survived for transfer with at least one being fully
intact. When embryos failed to resume mitosis during overnight culture,
additional embryos were thawed for immediate transfer. Embryos were
transferred in either a natural or a stimulated cycle.
Embryo scoring
Only those embryos with an appropriate number of evenly cleaved blas-
tomeres for the day p.i. (2–6 blastomeres on Day 2; 4–8 + on Day 3)
and ≤25% of fragmented cytoplasm were considered suitable for freezing.
As a measure of embryo quality at the time of freezing, we categorized the
embryos as having the optimal number of cells for the day p.i. (4 cells on
Day 2; 8 cells on Day 3), fewer cells than optimal (2–3 cells on Day 2; 4–7
cells on Day 3), or more cells than optimal. Embryos frozen on Day 1 had
both pronuclei still visible. Thawed embryos were scored immediately
after thawing and before transfer.
Randomization and outcomes
Couples were randomized after embryos had been selected for fresh
transfer and freezing. Consenting couples with at least two embryos for
freezing were randomized to control or intervention by the embryologist
performing cryopreservation, who opened sequentially numbered, sealed,
opaque envelopes. The allocation sequence was generated independently
of the study team using simple randomization. Couples were told which
treatment they had received only if they asked for the information. The
embryologist freezing and thawing the embryos was aware of the treat-
ment in order to select the correct solutions, but when circumstances
allowed, a second embryologist scored post-thaw survival.
The primary outcome of the study was the proportion of couples with
≥50% of embryos surviving freezing and thawing with all the blastomeres
intact. The secondary outcomes included cumulative live birth, stillbirth,
clinical pregnancy, miscarriage and ectopic pregnancy. Cumulative live
birth per couple was deﬁned as the birth of one or more live babies
from the fresh and all frozen cycles arising from a single oocyte retrieval.
Clinical pregnancies were identiﬁed by the presence of at least one gesta-
tional sac with a fetal heart beat at ultrasound scan 5 weeks after embryo
transfer. The outcome of all thawing cycles up to November 2009 have
been analysed, including the cycles in which embryos were thawed for
transfer and also those in which the couple did not wish to have
embryos transferred, but consented to have them thawed and their mor-
phology assessed before they were discarded.
Statistical analysis
In order to detect a difference of 25% (i.e. 50–75%) in the proportion of
couples with at least 50% of their embryos fully intact after thawing with
90% power at 5% signiﬁcance, 85 couples were required in each random-
ized arm. We aimed to recruit 100 couples in each group to allow for the
couples who may not return for embryo thawing.
The primary outcome, the proportion of couples with at least 50% of
embryos fully intact after thawing, was analysed by a x
2 test. To adjust
for any chance imbalance in prognostic factors (couple diagnosis,
parity and female age) and for the varying number of embryos thawed,
logistic regression was applied. The odds ratio (OR) and 95% conﬁdence
interval (CI) have been reported. Only couples with at least one embryo
thawed could be included in the analysis of the primary outcome. The sec-
ondary outcome was cumulative live birth following a fresh and one or
more frozen cycles, i.e. the proportion of couples randomized with at
least one live birth. OHSS patients who did not have a transfer in the
fresh cycle were included in the analysis. All couples randomized were
included in the analysis following an intention to treat approach. Cox
regression was applied to compare the time to ﬁrst live birth, with
adjustment for female age, diagnosis and parity. The hazard ratio (HR)
and 95% CI have been reported.
The Mann–Whitney U-test was applied to quantitative variables follow-
ing a non-normal distribution and the x
2 test to categorical variables. The
log rank test was used to compare time to ﬁrst thaw between the groups.
Embryo outcomes were analysed using techniques appropriate for the
non-independence of embryos within couples. Random effects logistic
regression was applied to compare categorical outcomes across the two
randomized groups. Data were analysed using the Statistical Package for
the Social Sciences (SPSS, Chicago, IL, USA; version 17) and STATA
(StataCorp, College Station, TX, USA; Release 8). P , 0.05 was considered
statistically signiﬁcant.
Results
Baseline characteristics
A total of 201 couples were recruited between September 2003 and
December 2006 (Fig. 1). Couples in the two groups had similar base-
line characteristics (Table I) although the intervention group had more
couples with male factor infertility. The median number of oocytes
collected, fertilized and available for freezing was similar across the
groups, as was the quality of embryos at freezing (Table I).
Outcome of thawing
A total of 137/201 (68%) couples had at least one embryo thawed;
more couples in the control (74/99; 75%) than intervention (63/
102; 62%) arm had embryos thawed (P ¼ 0.07) (Table II). The rate
at which couples returned for their ﬁrst thaw was similar across the
two groups (P ¼ 0.14). The number of thawing cycles did not differ
between groups, but more embryos were thawed per couple in the
control arm (P ¼ 0.06) (Table II).
Embryo survival
A greater proportion of couples had at least 50% of their embryos fully
intact after thawing in the intervention group (53/63; 84%), compared
with the control group (45/74, 61%; P ¼ 0.005). Freezing embryos in
a medium containing 0.3 M sucrose (intervention) increased the like-
lihood of a couple having at least 50% of their embryos fully intact
after thawing by 3.4-fold [95% CI (1.45, 7.82); P ¼ 0.005; adjusted
for number of embryos thawed, female age, parity and couple diagno-
sis]—a signiﬁcant improvement compared with control couples whose
embryos were frozen in medium with a conventional concentration of
sucrose (Table II).
In couples who had embryos thawed with the intention of autolo-
gous transfer, a signiﬁcantly greater proportion of the embryos thawed
were transferred in the intervention arm (P ¼ 0.02).
Clinical outcomes
When fresh and frozen cycles are combined, fewer intervention
couples had at least one live birth [43/102 (42%) versus 52/99
(53%); Table III]. Although this difference did not achieve signiﬁcance,
couples in the intervention arm were less likely to have at least one live
birth [HR ¼ 0.75, 95% CI (0.49, 1.13); P ¼ 0.17] (Fig. 2).
Sucrose concentration and survival of frozen embryos 1989Embryo transfer in the oocyte collection (fresh) cycle
Thirteen (6%) couples (four control; nine intervention) had no embryos
transferred in the oocyte collection cycle because the woman was at
riskofOHSS.Atotalof188coupleshadoneortwoembryostransferred
on Day 2 or Day 3 p.i., with the majority (93%) of transfers on Day 2
(88 control; 87 intervention). The distribution of transfers on Day 2 or
Day 3 did not differ between the groups. The outcome of the transfers
i ss h o w ni nd e t a i li nT a b l eIII.L i v eb i r t hr a t ep e rt r a n s f e rw a s3 5 / 9 5( 3 7 % )
in the control and 36/93 (39%) in the intervention group (P ¼ 0.91).
Theincidenceofmultiplebirth,ectopicpregnancy,termination,miscarriage,
stillbirth and neonatal death was similar in both groups.
Transfer of frozen-thawed embryos
Of the 67 control and 59 intervention couples who had embryos
thawed with the intention of autologous transfer, four control
couples had no surviving embryos and thus no transfer. The remain-
ing 63 control and 59 intervention couples had embryos transferred
[median number (interquartile range: IQR): control 2 (2,3); inter-
vention 2 (2,4)] in a similar number of transfers (89 versus 87,
respectively). Most couples (44 control; 37 intervention) had just
one cycle of thawing and transfer, but 19 control and 22 interven-
tion couples had two or more cycles. Two of the control and ﬁve
of the intervention couples had a ’mixed’ transfer, i.e. one frozen
and one non-frozen embryo transferred in cycles in which insufﬁ-
cient fresh embryos were available. For six couples, the clinical
outcome from the frozen embryo is unambiguous: ﬁve failed to
establish a pregnancy and one couple had dizygotic twins. All are
included in the analysis. The seventh couple (intervention group)
had a singleton birth that has been included in the analysis according
to the intention to treat principle.
Figure 1 Progress of participants through the RCT of conventional versus increased concentration sucrose in freezing and thawing solutions for
human embryos.
1990 Wood et al.The distribution of baseline characteristics of the couples who
received frozen embryo transfer in the two groups was similar to
the distribution displayed for all randomized patients (Table I).
Although we did not consider, a priori, the type of endometrial prep-
aration for embryo transfer to be an important prognostic factor,
there was—by chance—a slight excess of transfers in a natural cycle
in the control arm (36/63 versus 28/59).
More control couples than intervention couples had a live birth after
frozen embryo transfer [19/63 (30%) versus 9/59 (15%)] and this
difference was of borderline signiﬁcance (P ¼ 0.08) (Table III). There
is a similar disparity when the number of live births per embryo trans-
fer is calculated [21/89 (24%) versus 10/87 (11%)]. The incidence of
multiple birth, ectopic pregnancy, miscarriage, termination, stillbirth
and neonatal death was similar in both groups.
Survival of the frozen embryos
Overall, 60% (586/972) of embryos were thawed and all but three
were recovered and scored (Table IV). Signiﬁcantly more embryos
in the intervention group (196/267; 73%) than the control group
(180/316; 57%) were fully intact [OR (95% CI) 2.9 (1.6, 5.4); P ,
0.001]. When the less stringent deﬁnition of survival commonly
used by embryologists was applied, i.e. embryos with ≥50% of cells
intact, survival remained elevated in the intervention group [OR
(95% CI) 2.4 (1.3, 4.2); P ¼ 0.003].
Discussion
The results of this trial show that an increase in the concentration of
sucrose in the freezing medium, from 0.1 to 0.3 M, was associated
with higher rates of embryo survival, resulting in 23% (53/63 versus
45/74) more couples having at least 50% of their embryos fully
intact after thawing. This improved survival was not reﬂected in an
increase in the number of live births or in the cumulative live birth
rate after the embryos were transferred.
This is the ﬁrst trial examining the effect of changes in the sucrose
content of embryo-freezing medium in which couples were allocated
to treatment prospectively using a rigorous method of randomiz-
ation. Furthermore, the couple (not the embryo) was the unit of
primary analysis, reﬂecting the experimental design. Studies in
which the unit of analysis (embryo) does not match the unit of allo-
cation (couple) will lead to spuriously low P-values. Previously,
Jericho et al. (2003) and Edgar et al. (2009) reported increased blas-
tomere survival and a greater proportion of embryos surviving with
all blastomeres intact, when biopsied and non-biopsied embryos
were frozen in solutions with an elevated sucrose concentration
(0.2 versus 0.1 M). The biopsied embryo data were analysed retro-
spectively (Jericho et al., 2003), while Edgar et al. (2009) randomized
patients to treatment prospectively, but each freezing treatment was
carried out in a different clinic. In both studies, the embryo was the
unit of analysis although the patient was assigned to treatment. The
present study suffered a slight loss of power because only 137 of
the anticipated 170 couples had their embryos thawed. Nonetheless,
the results presented provide the strongest evidence to date that the
concentration of sucrose in the freezing medium is critical for blasto-
mere survival. In future studies, a greater allowance should be
made for the high proportion of couples who fail to return for
embryo thawing.
Data from retrospective studies suggest that the transfer of
embryos that survive freezing with all blastomeres intact increases
the likelihood of live birth (Van den Abbeel et al., 1997; Guerif
et al., 2002). It was hypothesized that increasing the proportion of
intervention couples with at least 50% of thawed embryos intact
would result in higher cumulative live birth rates. Since the present
study was not powered for the secondary outcome of cumulative
live birth, there is insufﬁcient evidence to conclude that one solution
is superior to the other. However, the data suggest that the true
effect of freezing embryos in a medium containing 0.3 M sucrose is
unlikely to be greater than a 1.13-fold increase in the rate of live
birth compared with control, while treatment using 0.3 M sucrose
could potentially reduce the live birth rate considerably. So, while
we must be cautious in our interpretation because of the small
sample size, our results suggest that freezing embryos in a medium
containing 0.3 M sucrose is unlikely to have any beneﬁcial effect on
clinical outcome and may in fact be detrimental when compared
with our standard practice of freezing in a medium containing 0.1 M
sucrose. A retrospective comparison of clinical data led Borini et al.
(2006) to question the clinical efﬁciency of freezing human oocytes
.................................................
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Table I Baseline characteristics of couples in RCT of
conventional versus increased concentration sucrose in
freezing and thawing solutions for human embryos.
Embryos frozen in a medium
containing
0.1 M sucrose
(control)
0.3 M sucrose
(intervention)
Number of couples (n) 99 102
Female age in years; mean
(SD)
34.3 (3.7) 34.3 (3.8)
Number of parous women
(%)
11 (11%) 4 (4%)
Couple’s diagnosis (%):
Male factor only 21 (21%) 35 (34%)
Female factor only 67 (68%) 55 (54%)
Both 11 (11%) 12 (12%)
Treatment (%):
IVF 73 (74%) 72 (71%)
ICSI 21 (21%) 28 (27%)
IVF and ICSI 5 (5%) 2 (2%)
Median (IQR
a) number of oocytes per patient:
Collected 11 (8, 14) 10 (8, 13)
Inseminated 10 (8, 14) 9 (7, 12)
Fertilized normally
b 7 (5, 10) 7 (5, 9.25)
Median (IQR) number of
embryos frozen per patient
4 (3, 6) 4 (3, 6)
Quality score at freezing:
Median (IQR) proportion
of embryos with optimal
number of cells at freezing
50 (20, 80) 50 (23.75, 75)
aInterquartile range.
bTwo pronuclei and two polar bodies.
Sucrose concentration and survival of frozen embryos 1991in solutions similar to those in the intervention arm of this study,
despite a signiﬁcant increase in oocyte survival and high rates of ferti-
lization. Thus evidence is accumulating to suggest that it is unwise to
rely on surrogate end-points, such as embryo survival, when assessing
changes in cryopreservation strategy. Future cryopreservation studies
should be adequately powered to detect clinically worthwhile
differences in cumulative live birth.
It is possible that the live birth rate after frozen embryo transfer
was inﬂuenced by the clinical strategy of thawing sufﬁcient embryos
to obtain the number required for transfer, with at least one
embryo fully intact. In a pragmatic trial where the intention is to
mirror normal clinical practice, it is inevitable that there will be con-
ﬂict with sound experimental design. However, it seems unlikely
that the outcome in this study was biased since the live birth rate
after frozen transfer amongst control couples was almost double
that of the intervention couples. The embryo selection policy
would have been expected to minimize differences between the
two groups.
Similarly, the excess of frozen embryo transfers in natural cycles in
the control arm of the trial (57 versus 48%), could have potentially
inﬂuenced the clinical outcome. Transfer in natural or stimulated
cycles was carried out entirely according to clinical protocols and
thus this disparity occurred purely by chance. To the best of our
knowledge, there is no conclusive evidence (Ghobara and Vander-
kerchove, 2008; Hill et al., 2010) to suggest that transfer in a natural
cycle is more favourable than transfer in a stimulated cycle. The inci-
dence of live birth after frozen embryo transfer in the control group
was double that in the intervention arm (Table III) and thus, although
this relatively small imbalance could either reduce or increase the
difference between live birth rate in the two arms, it is very unlikely
that it would result in the intervention treatment being superior
to control.
The requirement to use commercially available freezing and thawing
solutions made it impossible to change the concentration of sucrose in
the freezing medium without introducing confounding factors. The
slight reduction in PrOH concentration in the intervention group
(from 1.5 to 1.4 M) plainly had no deleterious effect on embryo
survival. The protein content of the two freezing media also differed,
but—since others have associated sucrose concentration with oocyte
(Fabbri et al., 2001) and embryo (Jericho et al., 2003; Zheng et al.,
2005; Edgar et al., 2009) survival—it seems likely that the increased
survival reported here in the intervention arm can be attributed to
the elevated sucrose. The inclusion of similar concentrations of
sucrose in both freezing and diluent solutions in the intervention
arm may not be optimal (Jericho et al., 2003; Bianchi et al., 2007;
Edgar et al., 2009), but nonetheless embryo survival was plainly
superior to that of controls.
Only 31% of the couples approached (201/652; Fig. 1), took part in
the trial but it is unlikely that this introduced bias in our study popu-
lation. Not unexpectedly, 40% of couples declined to take part in
research that might directly affect the outcome of their treatment.
Subsequently almost 50% (192/393) of those who gave informed
consent were excluded, mainly because they did not meet the
inclusion criterion of having at least two embryos suitable for
........................................................
.............................................................................................................................................................................................
Table II Outcome of thawing frozen embryos for couples wishing an autologoustransfer and for those couples consenting
to the embryos being observed and then discarded.
Embryos frozen in a medium containing P-value
0.1 M sucrose
(control)
0.3 M sucrose
(intervention)
Number of couples randomized n ¼ 99 n ¼ 102
Number (%) of couples with ≥1 embryo thawed 74 (75%) 63 (62%) 0.07
Median (IQR) number of embryos thawed 3 (0, 4) 2 (0, 4) 0.06
Median (IQR) number of thawing cycles 1.(0, 1) 1 (0, 1) 0.23
Number of thawing cycles
0 25 (25%) 39 (38%)
1 51 (52%) 39 (38%)
2 15 (15%) 13 (13%)
3 5 (5%) 8 (8%)
4–6 3 (3%) 3 (3%)
Total number of couples with embryo(s) thawed and morphology recorded
a n ¼ 74 n ¼ 63
Number (%) of couples with ≥50% embryos fully intact over all thawing cycles 45/74 (61%) 53/63 (84%) 0.005
b
Number of couples having embryos thawed with intention of autologous transfer
c n ¼ 67 n ¼ 59
Median (IQR) number of frozen embryos transferred
d 2 (2, 3) 2 (2, 4) 0.18
Median (IQR) proportion of embryos thawed that were transferred 0.67 (0.5, 0.8) 0.71 (0.5, 1.0) 0.02
aIncludes couples intending embryo transfer and those who allowed the embryos to be thawed and scored before being discarded.
bLogistic regression with adjustment for number of embryos thawed, female age, parity (yes/no), couple diagnosis (male only, female only, male and female).
cOne couple had embryos thawed for autologous transfer and also two embryos thawed for donation, these two embryos have not been included in further analysis.
dFresh embryos transferred in mixed transfers are not included.
1992 Wood et al.freezing—a proportion similar to that among all couples having treat-
ment in the ARU. A potential weakness of the trial concerns the lower
proportion of couples returning for frozen embryo transfer in the
0.3 M sucrose group. There is no reason to believe that the freezing
solution inﬂuenced a couple’s decision to return, especially because
similar levels of live birth occurred in the fresh cycle and couples
were blinded to treatment allocation unless they asked for the infor-
mation. Although it is likely that this difference has occurred by
chance, there is a small possibility that bias has been introduced.
However, the difference in embryo survival is so striking that it is unli-
kely that any bias introduced by the differential return rate would
change the overall result.
Recently many clinics have begun to vitrify embryos as an alternative
to freezing, mainly because of the higher rates of survival obtained
(Rama Raju et al., 2005; Balaban et al., 2008). However the clinical
superiority of vitriﬁcation over freezing has not been demonstrated
in RCTs (Kolibianakis et al., 2009). Vitriﬁcation has risks associated
with the use of unsealed containers and the storage of ultra-small
samples (Bielanski and Vajta, 2009; Wood, 2011) and it is too early
to be certain that it carries no risks for any children born. The low
rates of embryo survival so often reported after freezing in solutions
containing PrOH and 0.1 M sucrose are overcome by increasing the
concentration of sucrose as demonstrated here and elsewhere
(Jericho et al., 2003; Edgar et al., 2009). Although we were unable
......................................................................................
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Table III Clinical outcome.
Embryos frozen in a medium containing P-value
0.1 M sucrose (control) 0.3 M sucrose (intervention)
Number of couples randomized 99 102
Cumulative live births
a 52/99 (53%) 43/102 (42%) 0.17
b
Outcome of embryo transfer in fresh cycle
Number of couples having embryo transfer 95 93
Number of couples with live births 35/95 (37%) 36/93 (39%) 0.91
Number of babies born
Singleton 21 23
Twin 13
c 13
d
Triplet 1 0
Number of:
Clinical pregnancies 37 39
Miscarriages 2 1
Terminations 0 1
Ectopic pregnancies 0 1
Stillbirths 1 1
Neonatal deaths 1 0
Outcome of embryo transfer over all frozen cycles
Number of couples having ≥1 frozen embryo transfer 63 59
Number of couples with at least one live birth 19/63 (30%) 9/59 (15%) 0.08
Number of live births per embryo transfer
e 21/89 (24%) 10/87 (11%)
Number of babies born over all frozen embryo transfers
Singleton 16 8
Twin 5 2
Number of:
Clinical pregnancies 30 17
Miscarriages 7 5
Terminations 1 1
Ectopic Pregnancies 0 0
Stillbirths 1 1
Neonatal deaths 0 0
aCumulative live birth per couple is the birth of one or more live babies from the fresh and all frozen embryo transfer cycles arising from a single oocyte collection.
bCox regression adjusted for female age, female parity and couple diagnosis.
cIncludes two twin deliveries with one live birth and one stillbirth or neonatal death.
dIncludes one twin delivery with one live birth and one stillbirth.
eThree couples (two control and one intervention) had live births in two frozen transfer cycles.
Sucrose concentration and survival of frozen embryos 1993to show an improvement in clinical outcome after transfer of embryos
frozen in 0.3 M sucrose, Edgar et al. (2009) reported that freezing in a
medium containing 0.2 M sucrose increased the rate of implantation
per embryo thawed and thus the efﬁciency of the freezing programme.
It is plain that the outcome of freezing can be improved and it would
be prudent to retain an open mind as to the superiority of any cryo-
preservation approach until randomized controlled trials with live birth
as a primary outcome are reported.
Conclusion
This trial shows that increasing the concentration of sucrose from 0.1
to 0.3 M in the freezing medium improves survival in early stage
human embryos and signiﬁcantly increases the likelihood of a
couple having at least one fully intact frozen-thawed embryo for
transfer. It provides no evidence that the increased embryo survival
translates into increased cumulative birth rates for the couples
Figure 2 Time to ﬁrst live birth in groups allocated to control or intervention. For couples with more than one pregnancy leading to live birth, the
time to event is deﬁned by the number of years between randomization and the date of the ﬁrst live birth; subsequent live births are not included;
couples with no live birth were censored at the date the database was closed or at the date all their embryos were discarded or exported.
...............................................................................
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Table IV Survival of embryos after freezing and thawing.
Embryos frozen in a medium containing
0.1 M sucrose (control) 0.3 M sucrose (intervention) OR (95% CI); P
Number of embryos frozen 472 500
Total number of embryos (%) thawed
a 317 (67%)
b 269 (54%)
c
Number of embryos (%) recovered 316 (67%) 267 (53%)
Number of embryos (%) fully intact 180/316 (57%) 196/267 (73%) 2.9 (1.6, 5.4); ,0.001
d
Number of embryos (%) with ≥50% of blastomeres intact 252/316 (80%) 239/267 (90%) 2.4 (1.3, 4.2); 0.003
d
OR, odds ratio; CI, conﬁdence interval.
aIncludes embryos thawed for couples intending embryo transfer and those for couples who allowed observation of their embryos before they were discarded.
bFifteen embryos frozen on Day 1, 290 on Day 2 and 12 on Day 3 post insemination.
cTwenty three embryos frozen on Day 1, 224 on Day 2 and 22 on Day 3 post insemination.
dRandom effect logistic model includes random effect for couple and treatment effect is adjusted for day of embryo freezing.
1994 Wood et al.and has highlighted the need for robust clinical outcomes in labora-
tory trials.
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